Literature DB >> 17637649

Neurobiology: new order for thought disorders.

Lorna W Role, David A Talmage.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17637649     DOI： 10.1038/448263a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components.

Authors:  Ying-Jiun J Chen; Madeleine A Johnson; Michael D Lieberman; Rose E Goodchild; Scott Schobel; Nicole Lewandowski; Gorazd Rosoklija; Ruei-Che Liu; Jay A Gingrich; Scott Small; Holly Moore; Andrew J Dwork; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

2.  A Src link in schizophrenia.

Authors:  Chang-Gyu Hahn
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

3.  Sustained high levels of neuregulin-1 in the longest-lived rodents; a key determinant of rodent longevity.

Authors:  Yael H Edrey; Diana Casper; Dorothee Huchon; James Mele; Jonathan A Gelfond; Deborah M Kristan; Eviatar Nevo; Rochelle Buffenstein
Journal:  Aging Cell       Date:  2011-12-29       Impact factor: 9.304

Review 4.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

Review 5.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

Review 6.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Authors:  Lin Mei; Wen-Cheng Xiong
Journal:  Nat Rev Neurosci       Date:  2008-05-14       Impact factor: 34.870

Review 7.  Mechanisms of neuregulin action.

Authors:  David A Talmage
Journal:  Novartis Found Symp       Date:  2008

8.  Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice.

Authors:  Inga H Deakin; Amanda J Law; Peter L Oliver; Markus H Schwab; Klaus Armin Nave; Paul J Harrison; David M Bannerman
Journal:  Neuroreport       Date:  2009-11-25       Impact factor: 1.837

9.  Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches.

Authors:  Martin Begemann; Derya Sargin; Moritz J Rossner; Claudia Bartels; Fabian Theis; Sven P Wichert; Nike Stender; Benjamin Fischer; Swetlana Sperling; Sabina Stawicki; Anne Wiedl; Peter Falkai; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

10.  Transgenic overexpression of the type I isoform of neuregulin 1 affects working memory and hippocampal oscillations but not long-term potentiation.

Authors:  Inga H Deakin; Wiebke Nissen; Amanda J Law; Tracy Lane; Riam Kanso; Markus H Schwab; Klaus-Armin Nave; Karri P Lamsa; Ole Paulsen; David M Bannerman; Paul J Harrison
Journal:  Cereb Cortex       Date:  2011-08-30       Impact factor: 5.357
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.